ASBP vs GILD: Which Stock is Better?
Side-by-side comparison of Aspire Biopharma Holdings Inc and Gilead Sciences Inc in 2026
ASBP
Aspire Biopharma Holdings Inc
$5.41
GILD
Gilead Sciences Inc
$134.36
Key Metrics Comparison
| Metric | ASBP | GILD | Winner |
|---|---|---|---|
| Market Cap | $7.01M | $166.82B | GILD |
| P/E Ratio | N/A | 18.28 | GILD |
| EPS (TTM) | $N/A | $7.35 | GILD |
| Revenue Growth | 0.0% | 0.0% | GILD |
| Gross Margin | 16.3% | 79.4% | GILD |
Analyze ASBP
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ASBP or GILD a better investment?
Comparing ASBP and GILD: Aspire Biopharma Holdings Inc has a market cap of $7.01M while Gilead Sciences Inc has $166.82B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ASBP and GILD?
ASBP (Aspire Biopharma Holdings Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ASBP or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ASBP or GILD?
GILD has higher revenue growth at 0.0% vs 0.0% for ASBP.
Which company is more profitable: ASBP or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 79.4% compared to 16.3% for ASBP.
Which is the larger company: ASBP or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $166.82B compared to $7.01M for ASBP.
Should I buy ASBP or GILD in 2026?
Both ASBP and GILD have investment merit. ASBP trades at $5.41 while GILD trades at $134.36. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ASBP and GILD stock?
Key differences: Market Cap ($7.01M vs $166.82B), P/E Ratio (N/A vs 18.3x), Revenue Growth (0.0% vs 0.0%), Gross Margin (16.3% vs 79.4%).